Learn everything you need to know about Ambroxol-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings, ...

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over 12 months, whereas placebo patients worsened. Those with high-risk genes ...

Please provide your email address to receive an email when new articles are posted on . Although a high number of adverse events were logged, most were mild to moderate in severity. The effects of ...

Review the side-effects of Ambroxol as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) has started a safety review of medicines that contain ambroxol and bromhexine. The medicines are used as ...

Researchers at Lawson Research Institute are studying Ambroxol - a common cough medicine in Europe - as a potential treatment for dementia linked to Parkinson’s disease LONDON, Ont. – Dementia poses a ...

Medicines containing ambroxol or bromhexine carry a small risk for severe skin reactions, which include erythema multiforme and Stevens-Johnson syndrome, and the product labels should be updated to ...

Dementia poses a major health challenge with no safe, affordable treatments to slow its progression. Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care ...

A major trial to test whether a cough medicine will slow down Parkinson’s has been announced. Early studies suggest the drug, called ambroxol, appears to remove damaging proteins from the brain which ...

A commonly sold cough syrup in Europe could potentially slow down progression of dementia in patients with Parkinson’s disease, a new study suggests. Nearly half of those diagnosed with Parkinson’s ...